483 Brigham and Women's Hospital Aug 2019

483 Brigham and Women's Hospital Aug 2019

Robert Martin FDA$119.00 - Available Now

FDA investigators audited the Brigham and Women's Hospital - Boston, MA, United States facility and issued inspectional observations (via FDA 483) on 22 Aug 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Aug 2019
  • Location: Boston, United States
  • FEI: 3012030543
Add To Cart